title: Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
authors.affiliation: Hacettepe University, Faculty of Medicine, Department of Neurology, Ankara, Turkey.
authors.forename: Sefik Evren
authors.initials: SE
authors.lastname: Erdener
authors.affiliation: Hacettepe University, Faculty of Medicine, Department of Neurology, Ankara, Turkey. Electronic address: akurne@hacettepe.edu.tr.
authors.forename: Asli Tuncer
authors.initials: AT
authors.lastname: Kurne
authors.affiliation: Hacettepe University, Faculty of Medicine, Department of Neurology, Ankara, Turkey.
authors.forename: Sevda
authors.initials: S
authors.lastname: Diker
authors.affiliation: Hacettepe University, Faculty of Medicine, Department of Neurology, Ankara, Turkey.
authors.forename: Rana
authors.initials: R
authors.lastname: Karabudak
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009471:Neuromyelitis Optica / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents
keywords: CD19; EDSS; Immunosuppression; Neuromyelitis optica; Rituximab